Dysplastic nevus screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Patients with dysplastic nevus should undergo regular screening to prevent progression to melanoma. According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for skin tumors, including dysplastic nevus or melanoma.
Screening
Screening
According to the National Cancer Institute, physicians believe that dysplastic nevi are more likely than ordinary moles to develop into a type of skin cancer called melanoma. Because of this, moles should be checked regularly by a physician or nurse specialist, especially if they look unusual; grow larger; or change in color, or outline; or if any changes occur. According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for skin tumors, including dysplasytic nevus and melanoma.[1]
References
References
- ↑ “USPSTF Skin Cancer Screening”. Retrieved 20/8/2015. Check date values in:
|access-date=(help)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
